Ezetimibe: ~20% | First add-on, oral & well-tolerated Bempedoic acid: ~23% alone | ~38% with ezetimibe | Great for statin intolerance PCSK9 inhibitors: 5060% | For very high-risk patients, injected every 24 weeks Inclisiran: ~50% | Long-term maintenance, injected every 6 months Takeaway: LDL-lowering is no longer one-size-fits-all its personalized, potent, and more patient-friendly than ever
Medicare currently does not cover anti-obesity medications, with limited exceptions for cardiovascular indications
26% of study participants regained 25 to 99% of their lost weight
Understanding proper storage is essential for patients to ensure optimal therapeutic outcomes
If youre considering keeping the pregnancy, your provider can help you figure out the best way to manage your blood sugar and weight gain safely
Leffetto concentrato dove lo scheletro porta peso (colonna, anca, tibia) e sparisce nel radio distale, che un sito non portante